HQY Healthequity Inc
Price (delayed)
$88.74
Market cap
$7.68B
P/E Ratio
79.95
Dividend/share
N/A
EPS
$1.11
Enterprise value
$8.49B
HealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for its more than 12 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who
Highlights
HQY's net income has surged by 74% year-on-year
HQY's EPS has surged by 71% year-on-year
The debt has increased by 19% year-on-year but it has declined by 2.3% since the previous quarter
HQY's quick ratio is down by 39% year-on-year and by 4.7% since the previous quarter
Key stats
What are the main financial stats of HQY
Market
Valuations
Earnings
Shares outstanding
86.5M
Market cap
$7.68B
Enterprise value
$8.49B
Price to earnings (P/E)
79.95
Price to book (P/B)
3.64
Price to sales (P/S)
6.43
EV/EBIT
48.05
EV/EBITDA
25.03
EV/Sales
7.07
Revenue
$1.2B
Gross profit
$777.26M
Operating income
$162.33M
Net income
$96.7M
EBIT
$176.67M
EBITDA
$339.12M
Free cash flow
$286.64M
Per share
Balance sheet
Liquidity
EPS
$1.11
EPS diluted
$1.09
Free cash flow per share
$3.3
Book value per share
$24.4
Revenue per share
$13.81
TBVPS
$6.86
Total assets
$3.45B
Total liabilities
$1.33B
Debt
$1.11B
Equity
$2.11B
Working capital
$321.43M
Debt to equity
0.52
Current ratio
3.06
Quick ratio
2.65
Net debt/EBITDA
2.4
Margins
Efficiency
Dividend
EBITDA margin
28.3%
Gross margin
64.8%
Net margin
8.1%
Operating margin
13.5%
Return on assets
2.8%
Return on equity
4.6%
Return on invested capital
14.1%
Return on capital employed
5.4%
Return on sales
14.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HQY stock price
How has the Healthequity stock price performed over time
Intraday
1.94%
1 week
-0.54%
1 month
-19.15%
1 year
7.19%
YTD
-7.51%
QTD
0.42%
Financial performance
How have Healthequity's revenue and profit performed over time
Revenue
$1.2B
Gross profit
$777.26M
Operating income
$162.33M
Net income
$96.7M
Gross margin
64.8%
Net margin
8.1%
HQY's net income has surged by 74% year-on-year
The net margin has increased by 45% year-on-year but it has declined by 3.6% since the previous quarter
HQY's operating income is up by 38% year-on-year and by 2.1% since the previous quarter
The gross profit rose by 25% year-on-year and by 3.4% since the previous quarter
Growth
What is Healthequity's growth rate over time
Valuation
What is Healthequity stock price valuation
P/E
79.95
P/B
3.64
P/S
6.43
EV/EBIT
48.05
EV/EBITDA
25.03
EV/Sales
7.07
HQY's EPS has surged by 71% year-on-year
The P/E is 3.4% lower than the last 4 quarters average of 81.2
The stock's P/B is 12% above its 5-year quarterly average of 3.2
The equity has grown by 3.9% YoY
HQY's revenue is up by 20% year-on-year and by 4.3% since the previous quarter
The stock's price to sales (P/S) is 7% less than its last 4 quarters average of 6.8 and 6% less than its 5-year quarterly average of 6.7
Efficiency
How efficient is Healthequity business performance
The ROE has soared by 64% YoY
The ROA has soared by 56% YoY but it has contracted by 3.4% from the previous quarter
HQY's ROIC is up by 18% YoY but it is down by 2.1% QoQ
HQY's return on sales is up by 12% year-on-year but it is down by 3.3% since the previous quarter
Dividends
What is HQY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HQY.
Financial health
How did Healthequity financials performed over time
Healthequity's total assets is 159% higher than its total liabilities
HQY's quick ratio is down by 39% year-on-year and by 4.7% since the previous quarter
Healthequity's current ratio has decreased by 36% YoY and by 4.4% QoQ
The debt is 48% smaller than the equity
The debt has increased by 19% year-on-year but it has declined by 2.3% since the previous quarter
The debt to equity has grown by 13% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.